Skip to main content

They Are Still Pimping CV-19 Vax

By October 24, 2025Commentary1 min read

Some researchers are still trying to convince us that CV-19 vax is worth getting year-after-year-after-year.  As I never tire of pointing out, the studies on effectiveness, which are used to justify the endless receipt of these vaccines, are fatally flawed from a total inability to sort out the effect of ongoing multiple CV-19 infections in just about every single American.  The latest is a study from the VA allegedly assessing the 2024/25 version of the vaccine.  Those who received the CV-19 and flu vax at the same time were compared to those who only got the flu one.  Supposedly after 6 months the double-vaxed group had a 29% lower chance of having an ER visit for CV-19, a 39% lower chance of a hospitalization, and a 64% lower risk of a CV-19 death.  Confidence intervals were extremely wide, showing how poor the association was.  The effect was almost exclusively seen in older adults.  The effectiveness showed the usual waning in a relatively short period of time.   (NEJM Study)

Oh, and I should have mentioned, two of the researchers are Pfizer consultants.

Kevin Roche

Author Kevin Roche

The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry through Roche Consulting, LLC. Mr. Roche is available to assist health care companies through consulting arrangements and may be reached at khroche@healthy-skeptic.com.

More posts by Kevin Roche

Join the discussion 2 Comments

  • Joe K says:

    “At 6 months of follow-up, the estimated vaccine effectiveness was 29.3% (95% confidence interval [CI], 19.1 to 39.2) against Covid-19–associated emergency department visits (risk difference per 10,000 persons, 18.3; 95% CI, 10.8 to 27.6), 39.2% (95% CI, 21.6 to 54.5) against Covid-19–associated hospitalizations (risk difference per 10,000 persons, 7.5; 95% CI, 3.4 to 13.0), and 64.0% (95% CI, 23.0 to 85.8)”

    A – 29% effectiveness seems a pathetically weak level of effectiveness
    B – 39% effectiveness against hospitalization seem like a similar level of weak effectiveness
    C – A 64% effectiveness against death seems contrived and not very valid

    since the current risk of death, even for high risk individuals, is likely less than 0.1% (0.01% maybe?), then a 64% risk reduction doesnt seem very sucessful

  • Joe K says:

    following up on my comment, The current Sept/ october 2025 covid death rate in minnesota is about 0.00006% (annualized).

    Thats much better odds than being on the streets of chicago!

Leave a Reply to Joe KCancel reply